Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

ASML Shares Face Critical Technical Test

Andreas Sommer by Andreas Sommer
November 18, 2025
in Analysis, Semiconductors, Tech & Software, Trading & Momentum
0
ASML Stock
0
SHARES
108
VIEWS
Share on FacebookShare on Twitter

ASML, the Dutch semiconductor equipment manufacturer that serves as a critical supplier to the global chip industry, is showing concerning technical signals. Despite a recent modest gain, multiple technical indicators are flashing warning signs as trading volume surges and investor anxiety grows. Market participants are questioning whether the stock is positioned for a more significant correction.

Technical Indicators Paint Bearish Picture

From a chart analysis perspective, the outlook appears particularly challenging. ASML shares are currently trading below both their short-term and long-term moving averages, which represents a classic bearish signal. The stock has declined 5.16% since late October when a sell signal was triggered at a pivot high.

Key technical observations reveal:

  • Consistent declines: The equity has finished lower in six of the past ten trading sessions
  • Downward momentum: Over this same period, the cumulative loss totals 4.37%
  • Volume confirmation: The substantial increase in trading volume underscores the current market tension

Market Volatility Signals Investor Uncertainty

Recent trading sessions demonstrate growing unease around ASML. While shares ultimately closed with a 1.29% gain at $1,020, this positive finish masks significant intraday volatility. During the session, the price swung dramatically between $1,004 and $1,025, representing a 2.06% trading range that indicates substantial investor indecision. Despite the positive closing price, the underlying trend remains unstable.

Should investors sell immediately? Or is it worth buying ASML?

The volume activity stands out as particularly notable. Approximately 419,000 more shares changed hands compared to the previous session, clear evidence that market participants are either establishing new positions or liquidating existing ones.

Support Level Under Pressure

The convergence of negative moving average signals, the recent sell trigger, and weak performance over recent weeks creates a coherent narrative: ASML is firmly in a downward trend. The stock is currently finding technical support around the $1,010 level based on accumulated volume, but prevailing indicators suggest additional selling pressure may emerge.

Investors should monitor the coming sessions closely. A breach of this support level could potentially trigger more pronounced price declines as the current technical deterioration continues to unfold.

Ad

ASML Stock: Buy or Sell?! New ASML Analysis from March 25 delivers the answer:

The latest ASML figures speak for themselves: Urgent action needed for ASML investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

ASML: Buy or sell? Read more here...

Tags: ASML
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
Next Post
Kraft Heinz Stock

Kraft Heinz Shares Face Mounting Pressure as Analyst Sentiment Sours

Tesla Stock

Tesla's Strategic Shift: AI and Robotaxis Drive Bold New Vision

Bitcoin Stock

Bitcoin's Critical Juncture: Institutional Accumulation Amid Market Panic

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com